Cordlife Group (SGX:P8A) Other Current Payables: S$0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SGX:P8A Cordlife Group Ltd SGX:P8A
27 GF Score
Price S$0.13
GF Value S$0.14
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Cordlife Group Other Current Payables?

Cordlife Group SGX:P8A 27 Other Current Payables is S$0.00 Mil as of Jun. 2026. GuruFocus rates SGX:P8A with a GF Score™ of 27/100 and a GF Value™ of S$0.14 (Fairly Valued). The stock has 4 warning signs investors should review.

Cordlife Group's Other Current Payables for the quarter that ended in Jun. 2026 was S$0.00 Mil.

Cordlife Group's quarterly Other Current Payables declined from Dec. 2025 (S$9.10 Mil) to Mar. 2026 (S$0.00 Mil) but then stayed the same from Mar. 2026 (S$0.00 Mil) to Jun. 2026 (S$0.00 Mil).

Cordlife Group's annual Other Current Payables increased from Dec. 2023 (S$3.58 Mil) to Dec. 2024 (S$9.56 Mil) but then declined from Dec. 2024 (S$9.56 Mil) to Dec. 2025 (S$9.10 Mil).

Cordlife Group Other Current Payables Related Terms

Cordlife Group Other Current Payables Historical Data

* Premium members only.

The historical data trend for Cordlife Group's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cordlife Group Other Current Payables Chart

Cordlife Group Annual Data
Trend Jun15 Jun16 Jun17 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.60 3.35 3.58 9.56 9.10

Cordlife Group Quarterly Data
Jun19 Sep19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 9.10 0.00 0.00
SGX:P8A
27GF Score
Cordlife Group Ltd SGX:P8A
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cordlife Group Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of S$0.00 Mil mean?
Cordlife Group (SGX:P8A) has a Other Current Payables of S$0.00 Mil as of Jun. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Cordlife Group and its competitors.
Is Cordlife Group's Other Current Payables too high?
Cordlife Group's current Other Current Payables is S$0.00 Mil. Overall, Cordlife Group has a GF Score™ of 27/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cordlife Group's Other Current Payables compare to TMO and DHR?
Cordlife Group's Other Current Payables of S$0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Diagnostics & Research company?
A good Other Current Payables depends on the Medical Diagnostics & Research industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Cordlife Group and its competitors. Cordlife Group's current Other Current Payables is S$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cordlife Group stock overvalued right now?
Based on GuruFocus' analysis, Cordlife Group (SGX:P8A) is currently considered Fairly Valued. The stock's GF Value™ is S$0.14, compared to a current price of S$0.13 — trading 5.7% below its estimated fair value. The current Other Current Payables is S$0.00 Mil. Cordlife Group's overall GF Score™ is 27/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Cordlife Group (SGX:P8A), the current Other Current Payables is S$0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cordlife Group (SGX:P8A) Overvalued in 2026?

Based on GuruFocus' analysis, Cordlife Group stock appears to be undervalued. The current stock price of S$0.13 is trading 5.7% below its estimated GF Value™ of S$0.14. GuruFocus considers Cordlife Group to be Fairly Valued.

Key valuation signals for SGX:P8A:

  • Other Current Payables: S$0.00 Mil
  • GF Value™: S$0.14 vs. price of S$0.13 (5.7% below fair value)
  • GF Score™: 27/100 with 4 warning signs

No single metric tells the full story. See the SGX:P8A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cordlife Group Business Description

Other Exchanges CLIFF:USA
Address 1 Kim Seng Promenade, No. 15-01, Great World City East, Singapore, SGP, 237994
Cordlife Group Ltd is a consumer healthcare company dedicated to safeguarding the well-being of mother and child. Along with its subsidiaries, the company is engaged in the provision of diagnostics and cord blood banking services, which involve the processing and storage of cord blood stem cells. The group has two reportable segments as follows: the Banking segment, which derives maximum revenue, comprises the collection, processing, and banking of biological materials; and the Diagnostics segment, which comprises diagnostics testing services. Geographically, the group generates maximum revenue from Hong Kong, and the rest from the Philippines, India, Malaysia, Singapore, and other regions.
27GF Score

Get the complete analysis for SGX:P8A

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

S$0.13
Price
S$0.14
GF Value